Fitzsimons J T, Epstein A N, Johnson A K
Brain Res. 1978 Sep 22;153(2):319-31. doi: 10.1016/0006-8993(78)90410-9.
The two naturally occurring analogues of angiotensin II (AII), Asp1-Val5-AII and Asp1-Ile5-AII, were equally effective as intracranial dipsogens in the water-replete rat. Renin, synthetic tetradecapeptide renin substrate (SRS) and angiotensin I (AI) also produced copious drinking when injected into the brain, but the naturally occurring renin substrate of rat caused little drinking and was much less effective than SRS. Prior intracranial injection of pepstatin, a competitive antagonist of the renin-angiotensinogen reaction, reduced drinking in response to renin and SRS but not to AI and AII. Renin-, SRS- and AI-induced drinking were inhibited by the converting enzyme inhibitor SQ 20881 injected through the same intracranial cannula in antagonist to agonist ratio of 1000:1, whereas the AII response was enhanced, although not significantly so, and the carbachol response was unaffected. Finally, position 8 aliphatic substituted analogues of AII were competitive antagonists of AII-induced drinking, and also inhibited drinking induced by renin, SRS and AI injected through the same intracranial cannula, but they did not inhibit carbachol-induced drinking. In conclusion, the angiotensin-sensitive receptor for thirst does not accept SRS or AI. It responds best to AII.
血管紧张素II(AII)的两种天然存在类似物,即天冬氨酸1-缬氨酸5-AII和天冬氨酸1-异亮氨酸5-AII,在水充足的大鼠中作为颅内致渴剂同样有效。肾素、合成十四肽肾素底物(SRS)和血管紧张素I(AI)注射到脑内时也会引起大量饮水,但大鼠天然存在的肾素底物引起的饮水很少,且比SRS的效果差得多。预先颅内注射胃蛋白酶抑制剂(一种肾素-血管紧张素原反应的竞争性拮抗剂)可减少对肾素和SRS的饮水反应,但对AI和AII无此作用。通过同一颅内套管以1000:1的拮抗剂与激动剂比例注射转化酶抑制剂SQ 20881,可抑制肾素、SRS和AI诱导的饮水,而AII反应虽未显著增强,但卡巴胆碱反应不受影响。最后,AII的8位脂肪族取代类似物是AII诱导饮水的竞争性拮抗剂,也抑制通过同一颅内套管注射肾素、SRS和AI所诱导的饮水,但不抑制卡巴胆碱诱导的饮水。总之,对口渴敏感的血管紧张素受体不接受SRS或AI。它对AII反应最佳。